Reports on the two major deals by biotechnology company Millenium Pharmaceuticals Inc. that aimed at establishing a product pipeline for the company. Subsidiary companies that would be acquired by Millenium to have an established product pipeline; Planning of Millenium regarding the issue of more shares; Prospects for the subsidiary company after the deal.